Senescent Cell Derived Artificial Vesicle-Based Senolytic Sonovaccine Platform with Augmented Lymph Node Delivery and Antigen Cross-Presentation Efficacy.

Liang Zhang, Yubo Lai, Jia Wang, Lingling Liu, Jieyuan An, Mi Qu, Yuan Liang, Bijun Tan, Guodong Yang, Xuekang Yang, Lijun Yuan

Department of Ultrasound Medicine, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.Department of Ultrasound Medicine, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China. · pubmed

Paper

Abstract

The efficacy of senolytic vaccines aiming to clear senescent cells is limited by narrow antigen coverage and inefficient CD8

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims to enhance the efficacy of senolytic vaccines through a novel vesicle-based platform that improves antigen delivery and cross-presentation. This research is relevant as it addresses the root cause of aging by targeting senescent cells, which are implicated in age-related diseases and contribute to the aging process.

Author of this paper? Send a correction.